The global mobile gamma cameras market is projected to experience significant growth over the next decade, with its valuation expected to rise from USD 59.5 billion in 2023 to USD 89.8 billion by 2033, registering a steady CAGR of 4.2% during the forecast period. The increasing demand for portable diagnostic imaging solutions and advancements in nuclear medicine are driving this growth trajectory.
Growth Drivers
- Rising Demand for Point-of-Care Diagnostics: Mobile gamma cameras offer convenience and efficiency in diagnosing various conditions, including cardiovascular diseases and cancer.
- Technological Advancements: Development of compact, high-resolution cameras has enhanced portability and accuracy, boosting adoption across healthcare facilities.
- Increased Focus on Nuclear Medicine: The growing reliance on gamma imaging for functional diagnostics, particularly in neurology and oncology, is fueling market expansion.
Regional Outlook
- North America: Holds the largest market share due to advanced healthcare infrastructure and high adoption of nuclear medicine techniques.
- Europe: Expected to maintain a strong presence, supported by rising investments in medical imaging technologies.
- Asia-Pacific: Anticipated to witness the fastest growth, driven by increasing healthcare expenditures and expanding diagnostic capabilities in countries like India and China.
Market Opportunities
- Integration of AI and Machine Learning: Leveraging AI for enhanced image processing and diagnostics is a growing trend in the mobile gamma camera industry.
- Emerging Markets: Expansion in developing regions presents lucrative opportunities for manufacturers as healthcare systems modernize.
Future Outlook
The mobile gamma cameras market is positioned for steady growth, driven by advancements in diagnostic technologies and increasing healthcare awareness worldwide. As the demand for portable, efficient diagnostic tools continues to grow, the market is expected to thrive across both developed and emerging regions.
Competitive Landscape
Collaborations between manufacturers, end-users, and research institutions can lead to the development of innovative mobile gamma camera-based solutions for emerging applications.
The key strategies chosen by large companies include several growth strategies such as technology development, expansion as well and mergers and acquisitions to surge market share, reach and revenue.
- In 2023, Dilon Technologies announced the launch of its new mobile gamma camera, the Ranger Vision+. The Ranger Vision+ is a lightweight and compact mobile gamma camera that is designed for use in a variety of settings, including hospitals, clinics, and ambulances.
- In the same year, Gamma Medica announced the launch of its new mobile gamma camera, the NuVent. The NuVent is a high-resolution mobile gamma camera that is designed for use in nuclear medicine imaging procedures, such as SPECT and PET.
- In 2022, GE Healthcare announced the launch of its new mobile gamma camera, the Discovery NM/CT 570c. The Discovery NM/CT 570c is a hybrid mobile gamma camera that combines SPECT/CT imaging capabilities in a single device.
- In the same year, Philips Healthcare announced the launch of its new mobile gamma camera, the Ingenuity TF PET/CT. The Ingenuity TF PET/CT is a hybrid mobile gamma camera that combines PET/CT imaging capabilities in a single device.
Key Companies Profiled
- Digirad Corporation
- DDD-Diagnostic A/S
- Dilon Technologies, Inc.
- Spectrum Dynamics Medical
- GAEDE
- Medizinsysteme GmbH
- Beijing Hamamatsu Photon Techniques Inc.
- MIE America
- Mediso
- CLERAD
- CardiArc
A Detailed Full Report
Segmentation Analysis of the Mobile Gamma Cameras Market
Product Type:
- Single Head
- Double Head
- Triple Head
- Hand Held
Indication:
- Cardiac Imaging
- Breast Imaging
- Hepatobiliary Imaging
- GI Imaging
- Renal Imaging
- Brain Imaging
- Others
End-User:
- Hospitals
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Specialized Clinics
Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- The Middle East & Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube